Rice Hall James & Associates’s BioTelemetry, Inc. BEAT Stock Holding History

Rice Hall James & Associates’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-233,058	Closed	-$14.6M	–	308
2019 Q1	$14.6M	Sell	233,058 -92,201	-28%	-$6.33M	0.47%	78
2018 Q4	$19.4M	Sell	325,259 -125,615	-28%	-$7.54M	0.71%	42
2018 Q3	$29.1M	Sell	450,874 -218,202	-33%	-$12.2M	1.04%	25
2018 Q2	$30.1M	Sell	669,076 -29,299	-4%	-$1.17M	1.09%	22
2018 Q1	$21.7M	Buy	698,375 +286,366	+70%	+$9.42M	0.85%	35
2017 Q4	$12.3M	Buy	+412,009	New	+$11.9M	0.48%	83
2016 Q1	–	Sell	-117,940	Closed	-$1.38M	–	321
2015 Q4	$1.38M	Buy	+117,940	New	+$1.49M	0.08%	218

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Rice Hall James & Associates's BEAT Position: Q2 2019 in Review

Rice Hall James & Associates sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 233,058 shares — an estimated $14.6M sold.

Rice Hall James & Associates first reported a position in BEAT in Q4 2015 and held it in 7 quarters. The position peaked at $30.1M in Q2 2018. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

Rice Hall James & Associates reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
Rice Hall James & Associates sold 233,058 BioTelemetry, Inc. shares in Q2 2019, an estimated $14.6M.
Rice Hall James & Associates first reported a position in BioTelemetry, Inc. in Q4 2015 and held it in 7 quarters.
Rice Hall James & Associates's BioTelemetry, Inc. position peaked at $30.1M in Q2 2018.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Rice Hall James & Associates's 13F filing for Q2 2019, filed 1 Aug 2019.